Author

Elaine Thomas

Pfizer (United Kingdom)Primary ORCID profile (0000-0002-6904-5405 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Elaine ThomasiD1 paper · University Health Network

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Christopher O’CallaghaniD· 1 shared Claire Mary SmithiD· 1 shared Dani Do Hyang LeeiD· 1 shared Daniela Cardinale· 1 shared Mario Cortina‐BorjaiD· 1 shared Oriane GrantiD· 1 shared Richard M. AngelliD· 1 shared Robert E. HyndsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Christopher O’CallaghanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Donor-derived airway ALI model for high-throughput screening of antiviral combinations with concurrent analysis of antiviral efficacy and epithelial toxicity using ciliR

Daniela Cardinale, Oriane Grant, Dani Do Hyang Lee, Samuel Ellis, Robert E. Hynds, Richard M. Angell, Christopher O’Callaghan, Mario Cortina‐Borja, Elaine Thomas, Claire Mary Smith

The paper presents a donor-derived air-liquid interface model for screening antiviral combinations against RSV, with tools to assess efficacy and epithelial toxicity.

ERJ Open Research · Feb 16, 2026Peer-reviewedMicrobiology